Neothetics
Latest round
- Series C
Last raised
- Feb 2014
Total raised
- $37M
Investors
- 7
About Neothetics
Neothetics, Inc.Founded in 2007 and headquartered in San Diego, US, Neothetics, Inc. operates within the domain sales space., continuing operations under the Evofem name.com primarily operates as a domain sales platform offering premium domain names for immediate purchase or structured payment plans. Each domain aids businesses and individuals in enhancing their digital identity and brand visibility.In the most recent fiscal year of 2014, Neothetics reported no revenue. The EBITDA for the same year was USD -11,973,206. The revenue model centers on direct sales of domain names, allowing clients to purchase outright or through installment plans with prices varying in the thousands of USD, reflecting market demand.Neothetics, Inc. plans to enhance its product offerings and expand its market reach. Following its merger with Evofem Biosciences, the company will focus on integrating their offerings by 2018 and expanding further into English-speaking markets, improving their service delivery and customer engagement.
Who invested in Neothetics
7 investors across 4 rounds
See all investors in Neothetics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Neothetics
Who invested in Neothetics?
Neothetics has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neothetics raised?
Neothetics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Neothetics last raise money?
Neothetics's most recent round on record is a Series C, in Feb 2014.
What does Neothetics do?
Neothetics is a pharmaceuticals company.
Where is Neothetics headquartered?
Neothetics is headquartered in San Diego, US.
Which VCs invest in companies like Neothetics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Neothetics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Neothetics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.